Royal Bank of Canada’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-221,330
| Closed | -$10.3M | – | 6390 |
|
2019
Q2 | $10.3M | Buy |
221,330
+159,173
| +256% | +$7.38M | ﹤0.01% | 1322 |
|
2019
Q1 | $1.52M | Buy |
62,157
+29,453
| +90% | +$718K | ﹤0.01% | 2439 |
|
2018
Q4 | $466K | Buy |
32,704
+21,174
| +184% | +$302K | ﹤0.01% | 3188 |
|
2018
Q3 | $175K | Buy |
11,530
+1,392
| +14% | +$21.1K | ﹤0.01% | 3962 |
|
2018
Q2 | $171K | Sell |
10,138
-2,736
| -21% | -$46.1K | ﹤0.01% | 3934 |
|
2018
Q1 | $211K | Buy |
12,874
+9,363
| +267% | +$153K | ﹤0.01% | 3707 |
|
2017
Q4 | $44K | Sell |
3,511
-15,109
| -81% | -$189K | ﹤0.01% | 4498 |
|
2017
Q3 | $229K | Buy |
18,620
+17,684
| +1,889% | +$217K | ﹤0.01% | 3730 |
|
2017
Q2 | $8K | Sell |
936
-6,328
| -87% | -$54.1K | ﹤0.01% | 5154 |
|
2017
Q1 | $65K | Sell |
7,264
-37,315
| -84% | -$334K | ﹤0.01% | 4352 |
|
2016
Q4 | $392K | Buy |
44,579
+40,769
| +1,070% | +$358K | ﹤0.01% | 3275 |
|
2016
Q3 | $26K | Sell |
3,810
-7,500
| -66% | -$51.2K | ﹤0.01% | 4698 |
|
2016
Q2 | $40K | Sell |
11,310
-4,280
| -27% | -$15.1K | ﹤0.01% | 4526 |
|
2016
Q1 | $45K | Sell |
15,590
-19,945
| -56% | -$57.6K | ﹤0.01% | 4494 |
|
2015
Q4 | $151K | Sell |
35,535
-12,340
| -26% | -$52.4K | ﹤0.01% | 4015 |
|
2015
Q3 | $218K | Buy |
47,875
+37,554
| +364% | +$171K | ﹤0.01% | 3684 |
|
2015
Q2 | $74K | Buy |
+10,321
| New | +$74K | ﹤0.01% | 4521 |
|
2014
Q3 | – | Sell |
-16,225
| Closed | -$74K | – | 5584 |
|
2014
Q2 | $74K | Buy |
16,225
+12,825
| +377% | +$58.5K | ﹤0.01% | 4188 |
|
2014
Q1 | $16K | Sell |
3,400
-21,936
| -87% | -$103K | ﹤0.01% | 4744 |
|
2013
Q4 | $127K | Sell |
25,336
-624
| -2% | -$3.13K | ﹤0.01% | 3848 |
|
2013
Q3 | $161K | Buy |
25,960
+4,706
| +22% | +$29.2K | ﹤0.01% | 3680 |
|
2013
Q2 | $97K | Buy |
+21,254
| New | +$97K | ﹤0.01% | 3760 |
|